✦ LIBER ✦

EV01: A phase I trial in healthy HIV negative volunteers to evaluate a clade C HIV vaccine, NYVAC-C undertaken by the EuroVacc Consortium

✍ Scribed by Pierre-Alexandre Bart; Ruth Goodall; Tristan Barber; Alexandre Harari; Ana Guimaraes-Walker; Mona Khonkarly; Neil C. Sheppard; Yolanda Bangala; Marie-Joelle Frachette; Ralf Wagner; Peter Liljeström; Jean-Pierre Kraehenbuhl; Marc Girard; Jaap Goudsmit; Mariano Esteban; Jonathan Heeney; Quentin Sattentau; Sheena McCormack; Abdel Babiker; Giuseppe Pantaleo; Jonathan Weber

Book ID: 116960500
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 758 KB
Volume: 26
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2008.03.083

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I trial in HIV negative healthy

A phase I trial in HIV negative healthy volunteers evaluating the effect of potent adjuvants on immunogenicity of a recombinant gp120W61D derived from dual tropic R5X4 HIV-1ACH320

✍ S. McCormack; A. Tilzey; A. Carmichael; F. Gotch; J. Kepple; A. Newberry; G. Jon 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 234 KB

Corrigendum to “Lessons from IAVI-006, a

Corrigendum to “Lessons from IAVI-006, a Phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteers” [Vaccine 26 (2008) 6671–6677]

✍ A. Guimarães-Walker; N. Mackie; S. McCormack; T. Hanke; C. Schmidt; J. Gilmour; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 91 KB

Lessons from IAVI-006, a Phase I clinica

Lessons from IAVI-006, a Phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteers

✍ A. Guimarães-Walker; N. Mackie; S. McCormack; T. Hanke; C. Schmidt; J. Gilmour; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 498 KB